Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immuron Ltd ADR

Current price
2.58 USD +0.23 USD (+9.77%)
Last closed 2.47 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 14 988 845 USD
Yield for 12 month +28.15 %
21.11.2021 - 28.11.2021

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) to reduce the risk of contracting travelers' diarrhea in the United States, and Travelers' Diarrhea; and IMM-529, for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. Address: 62 Lygon Street, Carlton, VIC, Australia, 3053

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

6.41 USD

P/E ratio

Dividend Yield

Current Year

+1 197 396 USD

Last Year

+507 694 USD

Current Quarter

+1 562 893 USD

Last Quarter

+810 155 USD

Current Year

+868 600 USD

Last Year

+347 336 USD

Current Quarter

+1 048 538 USD

Last Quarter

+584 681 USD

Key Figures IMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 386 373 USD
Operating Margin TTM -78.73 %
PE Ratio
Return On Assets TTM -9.87 %
PEG Ratio
Return On Equity TTM -20.01 %
Wall Street Target Price 6.41 USD
Revenue TTM 3 576 639 USD
Book Value 0.077 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 303.6 %
Dividend Yield
Gross Profit TTM 1 740 079 USD
Earnings per share -0.46 USD
Diluted Eps TTM -0.46 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin -108.52 %

Dividend Analytics IMRN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.9351
Price Sales TTM 4.3736
Enterprise Value EBITDA -0.8638
Price Book MRQ 1.3233

Financials IMRN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IMRN

For 52 weeks

1.48 USD 5.96 USD
50 Day MA 2.3 USD
Shares Short Prior Month 9 089
200 Day MA 2.15 USD
Short Ratio 1.23
Shares Short 7 888
Short Percent 1.6 %

Dynamics of changes in the value of assets



0.20 USD Star Royalties Ltd +0.01 (+3.53%)
Detailed analytics


Detailed analytics


1.01 USD China Liaoning Dingxu Ecological Agriculture Development Inc 0 (0%)
Detailed analytics


0.066 USD Silver Range Resources Ltd 0 (0%)
Detailed analytics


6.72 USD Cornerstone Financial Corporation 0 (0%)
Detailed analytics